Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 877-888 of 4,306
Drug study icon
CompletedNCT01452919

A Physical Dependence Study in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Oakland
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Greece
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06791122

Effectiveness of investigational Digital Therapeutic in schizophrenia

This study is completed in the United States. It is testing investigational Digital Therapeutic for schizophrenia.

Multiple locations, including Imperial
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Drug study icon
CompletedNCT05693935

TV-44749 for schizophrenia

This study is completed in the United States, in Bulgaria, in China, .... It is testing TV-44749 for schizophrenia.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States, Bulgaria, China, ...
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT01051531

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to people with Schizophrenia

This study is completed in Australia, in New Zealand, in China, .... It focuses on schizophrenia.

Multiple locations, including Dandenong
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
Australia, New Zealand, China, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT07550387

HS-10380 for schizophrenia

This study is completed in China. It is testing HS-10380 for schizophrenia.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT01940159

Safety study of SEP-363856 in schizophrenia

This study is completed in the United States. It is testing SEP-363856 for schizophrenia.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00634348

Ziprasidone and Aripiprazole for schizophrenia

This study is completed in the United States. It is testing ziprasidone and Aripiprazole for schizophrenia.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT03629951

A Study for Schizophrenia Relapse Prediction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ahmedabad
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
India
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT06245213

ANAVEX3-71 in Adults With Schizophrenia

This study is active but not recruiting in the United States. It is testing ANAVEX3-71 for schizophrenia.

In Marlton
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Anavex Life Sciences Corp.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.